Results 71 to 80 of about 721 (165)

European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma [PDF]

, 2023
Osteosarcoma is a challenging disease requiring multidisciplinary management in expert centers for optimal outcome. There are no current international protocols or guidelines specific for pediatric and adolescent osteosarcoma.
Baecklund, F, Baumhoer, D, Bielack, SS, Boye, K, Fernández, CM, Gaspar, N, Harrabi, SB, Haveman, LM, Hecker-Nolting, S, Herold, N, Hiemcke-Jiwa, L, Kager, L, Martin, V, Palmerini, E, Strauss, SJ, van de Sande, MAJ, van Ewijk, R   +16 more
core  

Calibrating from Within: Multipoint Internal Calibration of a Quantitative Mass Spectrometric Assay of Serum Methotrexate. [PDF]

, 2020
BACKGROUND:Clinical LC-MS/MS assays traditionally require that samples be run in batches with calibration curves in each batch. This approach is inefficient and presents a barrier to random access analysis.
Bevins, Nicholas J, Cooper, Donald P, Dahlin, Jayme L, Fitzgerald, Robert L, Hoffman, Melissa A, Hoofnagle, Andrew N, Jarolim, Petr, Schmeling, Michael   +7 more
core   +1 more source

Taking Stock: UK National antidote availability increasing but further improvements are required

, 2015
Background A 2010/2011 audit of the Royal College of Emergency Medicine (RCEM) National Poisons Information Service (NPIS) UK guidelines on antidote availability demonstrated variable stocking of antidotes for the management of poisoned patients; the ...
Archer, J R H, Bailey, G P, Dargan, P I, Eddleston, Michael, Nash, S, Rehman, B, Thanacoody, R, Thomas, S H L, Thomson, J.P., Vale, J A, Wind, K, Wood, D M   +11 more
core   +3 more sources

EHA2024 Hybrid Congress

HemaSphere, Volume 8, Issue S1, June 2024.
wiley   +1 more source

P1202: INTENDED USE OF GLUCARPIDASE IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMA AND IMPAIRED RENAL FUNCTION – THE VALIDATE STUDY

HemaSphere, 2022
S. Liebig, S. Burock, I. Merz, F. Knörnschild, P. Kießling, K. Kappert, U. Keller, S. Schwartz   +7 more
doaj   +1 more source

PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC

HemaSphere, 2022
L. Schaff, M. Lobbous, D. Carlow, L. DeAngelis, L. B. Nabors, C. Grommes   +5 more
doaj   +1 more source

PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO RECEIVE HDMTX: PHASE 2

HemaSphere, 2022
A. De La Fuente, F. J. Peñalver, P. Herrera, R. Cordoba, C. Martinez Chamorro, M. T. Olave, I. Jarque, M. B. Navarro, M. Estévez   +8 more
doaj   +1 more source

メトトレキサート解毒剤グルカルピダーゼの母集団薬物動態-薬力学解析に基づく臨床応用に関する研究 [PDF]

東京薬科大学博士（薬学）2023年度doctoral ...
760, フカヤ, ユタカ, 深谷, 寛
core  

The Evolution of Methotrexate Applications: A Multidimensional Approach to Treating Various Disorders – A Literature Review [PDF]

IntroductionMethotrexate (MTX) is a key cytostatic and immunosuppressive drug widely used in oncology and autoimmune disease treatment. It acts as a folic acid antagonist, inhibiting DNA synthesis and cell division.
Chrzanowska , Emilia Gabriela, Grzebinoga , Adam, Kuźniar, Jakub Paweł, Roguska, Barbara, Szlążek , Julia, Szostak, Magdalena, Tamborski, Tomasz, Turek , Marta, Zagalska, Michalina, Ząbek, Adam Jan   +9 more
core   +1 more source

Correction:Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment [PDF]

, 2023
Al-Qahtani, Alanod D, Bashraheel, Sara S, Dömling, Alexander, Goda, Sayed K, Groves, Matthew R, Rashidi, Fatma B, Shaabani, Shabnam   +6 more
core   +1 more source